Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(22%)
Results Posted
50%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph not_applicable
6
67%
Ph phase_4
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Completed2
Recruiting2
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 41 (12.5%)
N/A6 (75.0%)

Trials by Status

enrolling_by_invitation111%
terminated111%
unknown333%
completed222%
recruiting222%

Recent Activity

2 active trials
Showing 5 of 9
enrolling_by_invitation

Potential Biomarkers and Pathogenic Mechanism for Reflux Aspiration-induced Lung Injury.

NCT06164639
recruitingphase_1

Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma

NCT05625594
recruitingnot_applicable

Hysteroscopy vs. Endouterine Aspiration in the Management of Trophoblastic Retention

NCT05789940
completednot_applicable

Gastrointestinal Physiological Conditions in Obesity and After Bariatric Surgery

NCT03783052
terminatedphase_4

Intra-articular Local Anesthetic Injection and Hematoma Aspiration

NCT02951884
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06164639

Potential Biomarkers and Pathogenic Mechanism for Reflux Aspiration-induced Lung Injury.

Enrolling By Invitation
NCT05625594Phase 1

Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma

Recruiting
NCT05789940Not Applicable

Hysteroscopy vs. Endouterine Aspiration in the Management of Trophoblastic Retention

Recruiting
NCT03783052Not Applicable

Gastrointestinal Physiological Conditions in Obesity and After Bariatric Surgery

Completed
NCT02951884Phase 4

Intra-articular Local Anesthetic Injection and Hematoma Aspiration

Terminated
NCT03326661Not Applicable

Peritonsillar Abscess: Aspiration Versus Tonsillectomy a Chaud

Unknown
NCT03081104Not Applicable

Operative Hysteroscopy and Ultrasound Guided Vacuum Aspiration Versus Blind Vacuum Aspiration for the Treatment of Missed Abortion

Unknown
NCT02460614Not Applicable

Effects of Rhinopharyngeal Retrograde Clearance in Children With Acute Viral Bronchiolitis

Completed
NCT01321060Not Applicable

Fluid Collections Management in Severe Acute Pancreatitis

Unknown

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9